Vice President, Investments
Emerging Company Development
North Carolina Biotechnology Center
Areas of Expertise
Entrepreneurship, Venture Capital, Pitch Competitions
Dr. Doelling is the Vice-President of Investments, Emerging Company Development at the NC Biotechnology Center in Durham, NC. She provides strategic direction to the team’s evaluation and execution of 15-20 annual investments, the management of a $15-20 million portfolio of existing investments and of the Center’s investments in angel and venture capital funds. In this role, Dr. Doelling administers a set of programs and activities designed to catalyze the start-up and growth of innovative life science companies in North Carolina. These programs and activities include making direct investments in early-stage companies, investments in angel and venture capital groups, coaching and mentoring of entrepreneurs, and providing connections to potential investors, partners, employees, service providers, and other resources.
Dr. Doelling has strong experience in life science product R&D leadership, including senior roles at Embrex/Pfizer, Integrated Laboratory Systems (ILS) and SCYNEXIS. Her background includes starting and managing research, development and commercial operations. Dr. Doelling received her Ph.D. in Biochemistry from Purdue University.